Zobrazeno 1 - 10
of 3 539
pro vyhledávání: ''
Autor:
William A. Hall, Theodore G. Karrison, Seth A. Rosenthal, Mahul B. Amin, Leonard G. Gomella, James A. Purdy, A. Oliver Sartor, Jeff M. Michalski, Mark G. Garzotto, Carmen Bergom, Ashesh B. Jani, Colleen A.F. Lawton, Jeffry P. Simko, Joan K. Moore, Elizabeth M. Gore, W. Robert Lee, Paul L. Nguyen, Brita L. Danielson, Howard M. Sandler, Felix Y. Feng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:266-274
The immunoinflammatory state has been shown to be associated with poor outcomes after radiation therapy (RT). We conducted an a priori designed validation study using serum specimens from Radiation Therapy Oncology Group (RTOG) 0521. It was hypothesi
Autor:
Nirav S, Kapadia, Gabriel A, Brooks, Mary Beth, Landrum, Lauren, Riedel, Pang-Hsiang, Liu, Andrea, Hassol, Amanda S, Tripp, Shalini, Jhatakia, Colleen M, Kummet, Nancy L, Keating
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:39-46
Radiation utilization for breast cancer and metastatic bone disease varies in modality, fractionation, and cost, despite evidence demonstrating equal effectiveness and consensus recommendations such as Choosing Wisely that advocate for higher value c
Autor:
Jacob Hogan, Amit Roy, Patricia Karraker, Jordan R. Pollock, Zachary Griffin, Neha Vapiwala, Jeffrey D. Bradley, Carlos A. Perez, Benjamin W. Fischer-Valuck, John C. Baumann, Brian C. Baumann
Publikováno v:
Int J Radiat Oncol Biol Phys
Radiation oncology (RO) has seen declines in Medicare reimbursement (MCR). However, there are no recent studies analyzing the contributions of specific billing codes to overall RO reimbursement. We compared total MCR for specific Healthcare Common Pr
Autor:
Lucinda Morris, Sandra Turner, Niluja Thiruthaneeswaran, Anita O'Donovan, Richard Simcock, Anthea Cree, Jane Phillips, Shabbir Alibhai, Martine Puts, Ewa Szumacher, Heather Lane, Arielle Berger, Meera Agar
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:934-945
PURPOSE: The management of older adults with cancer is rapidly becoming a significant challenge in radiation oncology (RO) practice. The education of future radiation oncologists in geriatric oncology is fundamental to ensuring that older adults rece
Autor:
Daniel Lin, Molly B. El Alam, Joseph Abi Jaoude, Ramez Kouzy, Jae L. Phan, Jacob H. Elnaggar, Brianna Resendiz, Andrea Y. Delgado Medrano, Erica J. Lynn, Nicholas D. Nguyen, Sonal S. Noticewala, Geena G. Mathew, Emma B. Holliday, Bruce D. Minsky, Prajnan Das, Van K. Morris, Cathy Eng, Melissa P. Mezzari, Joseph F. Petrosino, Nadim J. Ajami, Ann H. Klopp, Cullen M. Taniguchi, Lauren E. Colbert
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:974-984
Patients with localized squamous cell carcinoma of the anus (SCCA) who experience treatment toxicity or recurrences have few therapeutic options. Investigation into the microbiome's influence on treatment toxicity and its potential use as a predictiv
Autor:
Jessika Contreras, Amar Srivastava, Pamela Samson, Todd DeWees, Ramaswamy Govindan, Maria Q. Baggstrom, Daniel Morgensztern, Michael Roach, Shahed N. Badiyan, Jeffrey Bradley, Saiama Waqar, Clifford Robinson
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:742-748
Our purpose was to evaluate the maximum tolerated dose of hypofractionated proton beam radiation therapy with concurrent weekly carboplatin/paclitaxel in patients with stage II-III non-small cell lung cancer.A phase I trial was designed using the tim
Autor:
Yu, Wang, Tao, Zhang, Yilin, Huang, Wei, Li, Jingjing, Zhao, Yin, Yang, Canjun, Li, Luhua, Wang, Nan, Bi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:1154-1164
Consolidation durvalumab after chemoradiation therapy (CRT) has improved patient outcomes in stage III non-small cell lung cancer (NSCLC) since the practice-changing results of the PACIFIC trial, whereas real-world evidence regarding the PACIFIC regi
Autor:
Alan Nichol, Elisa K. Chan, Stephen Chia, Caroline Lohrisch, Nafisha Lalani, Lovedeep Gondara, Karen A. Gelmon, Daegan Sit, Eric Tran, Caroline Speers
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:861-869
Randomized clinical trials have shown that regional nodal irradiation (RNI) in patients with unselected N1 breast cancer improves breast cancer-specific survival. However, the benefit of RNI in women with biologically low-risk N1 breast cancer is unc
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:40-51
The omission of radiation therapy (RT) in older women with stage 1 estrogen-receptor-positive (ER+) breast cancer receiving endocrine therapy (ET) is an acceptable strategy based on randomized trial data. Less is known about the omission of ET with o
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:52-55